ENTRY       D00015                      Drug
NAME        Glutamine (USP);
            L-Glutamine (JP18);
            Levoglutamide;
            Endari (TN);
            Nutrestore (TN)
PRODUCT     ENDARI (Emmaus Medical)
FORMULA     C5H10N2O3
EXACT_MASS  146.0691
MOL_WEIGHT  146.1445
CLASS       Gastrointestinal agent
             DG01975  Agents for peptic ulcer
              DG02008  Gastric mucosal protectant
REMARK      Same as: C00064
            Therapeutic category: 2322
            ATC code: A16AA03
            Product: D00015<JP/US>
            Product (mixture): D04363<JP>
EFFICACY    Anti-ulcerative, Dietary supplement
  DISEASE   Sickle cell disease [DS:H00229]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A16 OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
               A16A OTHER ALIMENTARY TRACT AND METABOLISM PRODUCTS
                A16AA Amino acids and derivatives
                 A16AA03 Glutamine
                  D00015  Glutamine (USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Genetic, Enzyme, or Protein Disorder: Replacement, Modifiers, Treatment
              Glutamine
               D00015  Glutamine (USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             2  Agents affecting individual organs
              23  Digestive organ agents
               232  Peptic ulcer agents
                2322  Glutamines
                 D00015  Glutamine (USP); L-Glutamine (JP18)
            Risk category of Japanese OTC drugs [BR:br08312]
             Third-class OTC drugs
              Inorganic and organic chemicals
               L-Glutamine
                D00015  Glutamine (USP)
            Drug groups [BR:br08330]
             Gastrointestinal agent
              DG01975  Agents for peptic ulcer
               DG02008  Gastric mucosal protectant
                D00015  Glutamine
            Drugs listed in the Japanese Pharmacopoeia [BR:br08311]
             Chemicals
              D00015  L-Glutamine
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D00015
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D00015
DBLINKS     CAS: 56-85-9
            PubChem: 7847083
            ChEBI: 18050
            PDB-CCD: GLN
            LigandBox: D00015
            NIKKAJI: J9.170G
ATOM        10
            1   C1c C    23.8378  -17.4606
            2   C1b C    25.0254  -16.7178
            3   C6a C    22.6035  -16.7995
            4   N1a N    23.8787  -18.8587
            5   C1b C    26.2597  -17.3787
            6   O6a O    21.4451  -17.5952
            7   O6a O    22.6209  -15.4015
            8   C5a C    27.4472  -16.6416
            9   N1a N    28.6814  -17.3027
            10  O5a O    27.4704  -15.2435
BOND        9
            1     1   2 1
            2     1   3 1
            3     1   4 1 #Down
            4     2   5 1
            5     3   6 1
            6     3   7 2
            7     5   8 1
            8     8   9 1
            9     8  10 2
///
